Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Operating Income: 2009-2019

Historic Operating Income for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2019 value amounting to $72.3 million.

  • Neurocrine Biosciences' Operating Income rose 200.45% to $44.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $94.5 million, marking a year-over-year decrease of 32.49%. This contributed to the annual value of $72.3 million for FY2019, which is 95.92% up from last year.
  • As of FY2019, Neurocrine Biosciences' Operating Income stood at $72.3 million, which was up 95.92% from $36.9 million recorded in FY2018.
  • Over the past 5 years, Neurocrine Biosciences' Operating Income peaked at $72.3 million during FY2019, and registered a low of -$147.4 million during FY2016.
  • In the last 3 years, Neurocrine Biosciences' Operating Income had a median value of $36.9 million in 2018 and averaged -$7.4 million.
  • Per our database at Business Quant, Neurocrine Biosciences' Operating Income crashed by 56.44% in 2016 and then surged by 128.09% in 2018.
  • Neurocrine Biosciences' Operating Income (Yearly) stood at -$94.2 million in 2015, then tumbled by 56.44% to -$147.4 million in 2016, then rose by 10.86% to -$131.4 million in 2017, then surged by 128.09% to $36.9 million in 2018, then skyrocketed by 95.92% to $72.3 million in 2019.